Application no. and date | 14767892.4 (espacenet) (Federated) (European Patent Register), 20140314 | Patent/reg. no. and date | DK/EP 2970101, 20180606 | Publication date | 20160120 | Priority no. and date | US 201361782445 P, 20130314, US 201461934365 P, 20140131 | EP pub. no. and date |
EP 2970101 20160120 | Effective date | | Applicant/owner | Alkermes Pharma Ireland Limited, Connaught House 1 Burlington Road
Dublin 4, IE | Applicant ref. no. | P65398DK01 | Inventor | ZEIDAN, Tarek, A., 296 Lexington Street
Watertown, MA 02472, US, DUNCAN, Scott, 4 Wayte Road
Bedford, MA 01730, US, HENCKEN, Christopher, P., 36 Dwinell Street
Boston, MA 02132, US, WYNN, Thomas, Andrew, 94 North Street
Lexington, MA 02420, US, SANRAME, Carlos, N., 9 Rumford Road
Lexington, MA 02420, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/221 (2006.01) , C07C 219/08 (2006.01) , C07C 229/12 (2006.01) , C07C 229/16 (2006.01) , C07C 309/18 (2006.01) | Title | PRO-DRUGS AF FUMARATER OG DERES ANVENDELSE I BEHANDLING AF FORSKELLIGE SYGDOMME | Int. application no. | US2014027401 | Int. publication no. | WO2014152494 | Related patent (certificate) | CA 2022 00010 | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|